✦ LIBER ✦

193 Vinflunine (VFL) in first line treatment of malignant pleural mesothelioma (MPM): Final results of a European phase II study

✍ Scribed by Margery, J.; Dabouis, G.; Dark, G.; Taylor, H.; Pinel, M.C.; Cadic, V.; Ruffié, P.; Talbot, D.

Book ID: 118573876
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 45 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(07)70269-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-432 Vinflunine (VFL) in first line tre

P-432 Vinflunine (VFL) in first line treatment of malignant pleuralmesothelioma (MPM): Final results of a phase II study

✍ Talbot, D.; Margery, J.; Dabouis, G.; Dark, G.; Taylor, H.; Macha, H.; Pinel, M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 519 KB

Carboplatin Plus Pemetrexed as First-lin

Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study

✍ Nikolaos Katirtzoglou; Ioannis Gkiozos; Nektaria Makrilia; Emilia Tsaroucha; Agg 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 349 KB

P-428 A phase II study of pemetrexed and

P-428 A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)

✍ Soto Parra, H.; Zucali, P.; Favaretto, A.; Grossi, F.; Fusi, A.; Marangolo, M.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Phase II study of pemetrexed and carbopl

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

✍ Ceresoli, G L; Zucali, P A; Mencoboni, M; Botta, M; Grossi, F; Cortinovis, D; Zi 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 265 KB

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo

P-574 Vinflunine (VFL) and cisplatin (Co

P-574 Vinflunine (VFL) and cisplatin (Coop) combination in first linetreatment of advanced non-small-cell lung cancer (NSCLC). Final results of a phase II study

✍ Souquet, P.; Ramlau, R.; Sun, X.; Lopez-Vivanco, G.; Pinel, M.; Colin, C.; Krazn 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB